Skip to main content
Journal ArticleOPEN ACCESS

Vital Signs: Hepatitis C Treatment Among Insured Adults — United States, 2019–2020

  • Thompson W
  • Symum H
  • et al.
MMWR. Morbidity and Mortality Weekly Report (2022) 71(32) 1011-1017
DOI: 10.15585/mmwr.mm7132e1
66Citations
Citations of this article
39Readers
Mendeley users who have this article in their library.

Abstract

Introduction: Over 2 million adults in the United States have hepatitis C virus (HCV) infection, and it contributes to approximately 14,000 deaths a year. Eight to 12 weeks of highly effective direct-acting antiviral (DAA) treatment, which can cure ≥95% of cases, is recommended for persons with hepatitis C.

References Powered by Scopus

Association between sustained virological response and all-cause mortality among patients with chronic hepatitis C and advanced hepatic fibrosis

JAMA
1304Citations
N/AReaders
Get full text

Pathogenesis, natural history, treatment, and prevention of hepatitis C

Annals of Internal Medicine
815Citations
N/AReaders
Get full text

Oral direct-acting agent therapy for hepatitis c virus infection: A systematic review

Annals of Internal Medicine
588Citations
N/AReaders
Get full text
View more at Scopus

Cited by Powered by Scopus

A National Hepatitis C Elimination Program in the United States: A Historic Opportunity

JAMA
65Citations
N/AReaders
Get full text

Progress towards elimination of viral hepatitis: a Lancet Gastroenterology & Hepatology Commission update

The Lancet Gastroenterology and Hepatology
29Citations
N/AReaders
Get full text

Estimated Prevalence and Awareness of Hepatitis C Virus Infection Among US Adults: National Health and Nutrition Examination Survey, January 2017–March 2020

Clinical Infectious Diseases
27Citations
N/AReaders
Get full text
View more at Scopus

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Thompson, W. W., Symum, H., Sandul, A., Gupta, N., Patel, P., … Wester, C. (2022). Vital Signs: Hepatitis C Treatment Among Insured Adults — United States, 2019–2020. MMWR. Morbidity and Mortality Weekly Report, 71(32), 1011–1017. https://doi.org/10.15585/mmwr.mm7132e1

Readers over time

‘22‘23‘24‘2506121824

Readers' Seniority

Tooltip

Researcher 9

47%

PhD / Post grad / Masters / Doc 8

42%

Professor / Associate Prof. 1

5%

Lecturer / Post doc 1

5%

Readers' Discipline

Tooltip

Medicine and Dentistry 5

38%

Nursing and Health Professions 3

23%

Immunology and Microbiology 3

23%

Social Sciences 2

15%

Article Metrics

Tooltip
Mentions
Blog Mentions: 1
News Mentions: 118
Social Media
Shares, Likes & Comments: 71

Save time finding and organizing research with Mendeley

Sign up for free
0